Pages: 1
1 NOTICES: mesothelin Targeted Immunotoxins for the Treatment of Cancer
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in US Patent application 61/535,668 entitled ``Pseudomonas Exotoxin A with Less
2 NOTICES: Standard on Asbestos in Construction
On March 30, 2012, the Department of Labor (DOL) will submit the Occupational Safety and Health Administration (OSHA) sponsored information collection request (ICR) titled, ``Standard on Asbestos in Construction'' to the Office of Management and Budget (OMB) for review and approval for continued use, in accordance with the Paperwork [[Page 20435]]
3 NOTICES: Mesothelin Monoclonal Antibodies for the Treatment of Human Cancers
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive evaluation option license to practice the inventions embodied in U.S. Patent Application 61/040,005 entitled ``Human Monoclonal Antibodies
Years: 20002001200220032004200520062007200820092010201120122013Pages: 1